雅仕維(01993.HK)獲授兩份廣吿資源營運合約
格隆匯6月3日丨 雅仕維(01993.HK)公吿,公司間接全資附屬公司上海雅仕維廣吿傳播有限公司("上海廣吿傳播")獲吿知,其已獲:(i)香港鐵路有限公司附屬公司港鐵軌道交通(深圳)有限公司("港鐵(深圳)")授出有關深圳地鐵4號綫的廣吿資源營運合約,為期2年,自2024年7月1日開始;及(ii)港鐵中鐵電化軌道交通(深圳)有限公司("港鐵中鐵軌道",為香港鐵路有限公司、中國中鐵電氣化局集團有限公司及深圳市特區建設發展集團有限公司合資企業)授出有關深圳地鐵13號綫的廣吿資源營運合約,期限暫定由2024年11月1日起至2026年6月30日屆滿(統稱"特許空間")。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.